• Mashup Score: 4

    Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world’s media organizations, industry events and directly to consumers. All quotes delayed a minimum of 15…

    Tweet Tweets with this article
    • Thanks so much for joining today's #AskReuters chat! Subscribe to our newsletter for more health and world news: https://t.co/ALddccvRJD https://t.co/fP2VH1UUqR

  • Mashup Score: 6

    Lung cancer is the second most diagnosed cancer in both individuals and is far and away the most lethal form of cancer. It is also the most preventable cancer. As with many other forms of cancer, prevention and early detection are key to reducing your risk.

    Tweet Tweets with this article
    • The COVID-19 pandemic has resulted in many cancer screenings being put on hold. This is true for #lungcancer screenings. It is so important to get patients who meet the eligibility criteria back in for their screenings! https://t.co/dH1KjTL2lt #AskReuters #LCSM https://t.co/w1h8IKUXd1

  • Mashup Score: 19

    Molecular profiling can offer some lung cancer patients a personalized treatment approach that’s often more effective than chemotherapy. Anne Tsao, M.D., shares who should receive genetic testing and which tests they need.

    Tweet Tweets with this article
    • Based on a tumor’s molecular profile, lung cancer treatment can be customized to target the tumor’s unique cellular characteristics. Our Dr. Anne Tsao explains why all lung cancer patients should have biomarker testing: https://t.co/kNZb6k2qeH #AskReuters #ASCO21 #EndCancer https://t.co/fGyx02JJFU

  • Mashup Score: 4

    In this issue of Cancer Cell, Gay et al. describe a molecular classification of small cell lung cancers and extend prior studies that highlight the potential for personalized treatments. Notably, they identify a new “inflamed” subtype that may emerge following acquired chemoresistance but which may become more susceptible to immunotherapy.

    Tweet Tweets with this article
    • A9. Agree - we are getting there. Lots of great work emerging in #SCLC from multiple groups. New biomarkers and understanding how SCLC adapts to therapy to become resistant will propel progress. #AskReuters #ASCO21 https://t.co/Sa1hynoprf https://t.co/7e6HX56bDI https://t.co/qgJEMb05w5

  • Mashup Score: 3
    • Healthcare experts take your questions about cancer care during #ASCO2021.

      Read the original tweet here

    Tweet Tweets with this article
    • Welcome to the #AskReuters Twitter chat. For the next hour, we will be discussing advancements in lung-cancer care as #ASCO21 kicks off. Follow our experts here: https://t.co/bkWnbafKri https://t.co/bQdnKNIvm4

  • Mashup Score: 30

    These decision aids are intended to help pregnant individuals make informed decisions regarding the COVID-19 vaccines in pregnancy

    Tweet Tweets with this article
    • A4: As a breastfeeding mom, I decided to get vaccinated based on how mRNA vaccines work, current data, recommendations by CDC, ACIP, ACOG, SMFM. Sharing a great decision-making tool for pregnant/breastfeeding women #AskReuters https://t.co/SJxBunqPbK 1/2 https://t.co/zuCYbaXYJF